WillItSurvive
YC Fall 2025 · United States

Clicks

AI agents that automate back-office healthcare billing and claims work.

Protection under test
Assessed 27 July 2026 · Evidence as of 27 July 2026
Something worth protecting exists and is being tested right now.
On the recordSince 27 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: Expected Series A or extended Seed round announcement given active SF hiring
The call

Clicks sells table-stakes AI billing automation into a market where bigger, better-funded players already ship the same features, and it has not yet named a customer or a defended niche.

Clicks makes software that uses AI to handle medical billing and revenue collection tasks for healthcare providers. The problem is that bigger companies like athenahealth and Epic have already built similar AI tools into their systems, and well-funded startups like Candid Health and Adonis are competing aggressively. Clicks claims to be easier to set up and use, but so do all its competitors, which means those features alone do not make it special. The company could stand out if it picked one narrow corner of the market (like helping rural clinics or handling just one type of billing problem) and dominated that space first, or if it publicly names and keeps important customers, though neither has happened yet.

Why
01
AI pressure: Anthropic and OpenAI computer-use agents. General-purpose computer-use agents can already do the task-automation work Clicks sells, shrinking its technical edge. Could AI do the core job? Yes, likely.
02
Bigger players: athenahealth (athenaOne AI billing features) and Epic (Agent Factory). athenahealth has shipped dozens of native AI RCM features inside athenaOne; Epic is building its own agent platform for the same hospitals Clicks wants. Could a giant copy it? Yes, easily.
03
What protects it. None confirmed yet; a possible edge is serving rural hospitals and legacy practice-management systems that Epic and athenahealth do not prioritize.
What would change this call
Clicks announces a Series A or extended Seed round within 6 months. Would show investors see traction despite no named logos yet.
Clicks publishes 2-3 named customer wins with retention data. Would show its RCM niche is real and defensible, not just a pivot.
athenahealth or Epic ships new native RCM-AI features into athenaOne or Agent Factory. Would show incumbents closing the gap Clicks depends on staying open.
Key numbers
  • Candid Health raised $120M, serves 200+ orgs (2026-07-22)
  • Clicks joined YC Fall 2025 batch (2025-09-01)
  • No named Clicks customer logos found (2026-06-17)
Named risks
  • EHR incumbents Epic and athenahealth shipping native AI RCM features threaten to disintermediate point solutions like Clicks. Severity: high
  • No documented proprietary data, integration exclusivity, or regulatory edge distinguishes Clicks from rivals. Severity: high
  • Well-funded direct competitors Candid Health ($120M) and Adonis ($40M) already have named enterprise logos Clicks lacks. Severity: high
  • Recent full vertical pivot from recruiting automation to healthcare RCM signals unproven product-market fit. Severity: medium
  • No named customers or independently verified traction metrics as of June 2026. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Candid Healthlosing toRaised $120M and serves 200+ orgs by July 22 2026 versus Clicks's zero named customers
Adonislosing toRaised $40M with Mount Sinai as customer and 130%+ retention by March 24 2026
athenahealthlosing toShipped 80+ native AI RCM features inside athenaOne by July 9 2026
Epiclosing toPreviewed no-code Agent Factory for RCM automation, reported July 9 2026
AKASAcontestingEstablished generative-AI RCM automation vendor since 2019, prior competitor in same niche
Ember (YC-backed)contestingDirect YC-backed RCM-AI peer claiming 16% net revenue increase (vendor-claimed)
Questions people ask
Is Clicks profitable in 2026?
No revenue figures are disclosed. As of June 17 2026 Clicks lists no revenue, no named customers, and 1-10 employees, and is a YC Fall 2025 startup still pivoting its target vertical, so profitability has not been established.
Could AI replace Clicks?
Clicks itself sells AI agents that automate RCM tasks, but the same automation is being shipped by athenahealth (80+ AI RCM features by July 9 2026) and Epic's Agent Factory, meaning larger platforms could absorb Clicks's function directly.
Who are Clicks's biggest competitors?
Candid Health raised $120M on July 22 2026 serving 200+ healthcare organizations, and Adonis raised $40M on March 24 2026 with Mount Sinai as a customer, both far ahead of Clicks which has no named logos as of June 2026.
Who owns Clicks?
Clicks is a privately held, venture-backed startup and member of Y Combinator's Fall 2025 batch, per ycombinator.com. No confirmed primary-source funding round size or investor list has been verified as of June 2026.
Has Clicks changed its business focus?
Yes. Clicks originally targeted back-office automation for recruiting and executive search firms as of October 31 2025, then fully pivoted to healthcare revenue cycle management, rebranding as Clicks Health by June 17 2026.
Does Clicks have a moat against Epic or athenahealth?
No proprietary data, exclusive integrations, or regulatory advantage is documented. Clicks's claimed differentiators, HIPAA and SOC2 compliance and no rip-and-replace integration, are also claimed by rivals Adonis, AKASA, and Candid Health.
Timeline
  • 2026-07-22Competitor Candid Health raises $120M Series led by Sixth Street Growth, serves 200+ orgs
  • 2026-07-09athenahealth reported with 80+ AI RCM features; Epic previews Agent Factory
  • 2026-06-17Clicks site fully repositioned as Clicks Health, targeting RCM firms and rural hospitals
  • 2026-03-24Competitor Adonis raises $40M, cites 4x revenue growth and Mount Sinai as customer
  • 2025-10-31Clicks originally described as automation for recruiting and executive search firms
  • 2025Clicks founded, joins Y Combinator Fall 2025 batch
Revision history
27 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources